⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7514573 | 0.70 | — | — | |
| SCHEMBL3464092 | 0.70 | — | — | |
| SCHEMBL3464312 | 0.70 | — | — | |
| SCHEMBL3826416 | 0.70 | — | — | |
| SCHEMBL3463247 | 0.70 | — | — | |
| SCHEMBL4264138 | 0.70 | — | — | |
| SCHEMBL11601366 | 0.68 | — | — | |
| SCHEMBL4907605 | 0.65 | — | — | |
| SCHEMBL8863494 | 0.63 | — | — | |
| SCHEMBL17460083 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8052896-B2 | Nanocarbon film and producing method thereof | FUJIFILM CORPORATION (JP) | 2011-11-08 | — | — | US | disclosed |
| US-7871539-B2 | Liquid crystal composition, liquid crystal element, reflective display material, light-controlling material, and method of preparing liquid crystal composition | FUJIFILM CORPORATION (JP) | 2011-01-18 | — | — | US | disclosed |
| US-7718086-B2 | Dichroic dye, and liquid crystal composition and liquid crystal device using the same | FUJIFILM CORPORATION (JP) | 2010-05-18 | — | — | US | disclosed |
| US-7713437-B2 | Liquid crystal composition, liquid crystal element, reflective display material, and light-controlling material | FUJIFILM CORPORATION (JP) | 2010-05-11 | — | — | US | disclosed |
| US-20090218549-A1 | Nanocarbon film and producing method thereof | FUJIFILM CORPORATION (JP) | 2009-09-03 | — | — | US | disclosed |
| US-20080292817-A1 | LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL ELEMENT, REFLECTIVE DISPLAY MATERIAL, LIGHT-CONTROLLING MATERIAL, AND METHOD OF PREPARING LIQUID CRYSTAL COMPOSITION | FUJIFILM CORPORATON (JP) | 2008-11-27 | — | — | US | disclosed |
| US-7402331-B2 | Liquid crystal element | FUJIFILM CORPORATION (JP) | 2008-07-22 | — | — | US | disclosed |
| US-7396573-B2 | Liquid crystal display element and light-modulating material | FUJIFILM CORPORATION (JP) | 2008-07-08 | — | — | US | disclosed |
| US-20080099724-A1 | Dichroic dye, and liquid crystal composition and liquid crystal device using the same | FUJIFILM CORPORATION | 2008-05-01 | — | — | US | disclosed |
| EP-1916279-A2 | Dichroic dye, and liquid crystal composition and liquid crystal device using the same | FUJIFILM Corporation (JP) | 2008-04-30 | — | — | EP | disclosed |
| US-7316829-B2 | Liquid crystal composition and display device | FUJIFILM CORPORATION (JP) | 2008-01-08 | — | — | US | disclosed |
| US-20070278449-A1 | Liquid crystal composition, liquid crystal element, reflective display material, and light-controlling material | FUJIFILM CORPORATION | 2007-12-06 | — | — | US | disclosed |
| US-20070131903-A1 | Dichroic dye and a low molecular weight gelling agent, high display performance | FUJIFILM CORPORATION | 2007-06-14 | — | — | US | disclosed |
| US-20070071911-A1 | pair of electrodes of which at least one is a transparent electrode and a liquid crystal layer between; liquid crystal layer contains at least two compositions of dual frequency addressable smectic liquid crystal compositions having different threshold voltages; a guest-host type liquid crystal element | FUJI PHOTO FILM CO., LTD. | 2007-03-29 | — | — | US | disclosed |
| US-20060269696-A1 | Liquid crystal composition and display device | FUJI PHOTO FILM CO., LTD. (JP) | 2006-11-30 | — | — | US | disclosed |
| US-6916800-B2 | Combination therapy including a matrix metalloproteinase inhibitor and an antineoplastic agent | PFIZER INC (US) | 2005-07-12 | — | — | US | disclosed |
| US-6858598-B1 | Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia | G. D. SEARLE & CO. (US) | 2005-02-22 | — | — | US | disclosed |